Trial
NCT01224795
A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
BioCryst Pharmaceuticals
Collaborators
Department of Health and Human Services
Condition
Influenza
Intervention
Peramivir
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-10